Michel Koole

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 17

Top Topics

Positron Emission Tomography

Cognitive Impairment

Convolutional Neural Network

Top Venues

European journal of nuclear medicine and molecular imaging

This page only lists publications with an associated author ORCID identifier.

Publications

Niloefar Ahmadi Bidakhvidi, Thomas Gevaert, Maxim De Schepper, Marcella Baldewijns, Enrique Havinga, Wies Deckers, Annouschka Laenen, Gaëtan Devos, Alexander Giesen, Steven Joniau, Michel Koole, Wouter Everaerts, Christophe M Deroose, Karolien E Goffin
Comparison of PSMA immunohistochemistry scoring systems to parametric [ 18 F]PSMA-1007 PET/MRI in primary prostate cancer. European journal of nuclear medicine and molecular imaging (2024)
Joke De Vocht, Donatienne Van Weehaeghe, Fouke Ombelet, Pegah Masrori, Nikita Lamaire, Martijn Devrome, Hilde Van Esch, Mathieu Moisse, Michel Koole, Patrick Dupont, Koen Van Laere, Philip Van Damme
Differences in Cerebral Glucose Metabolism in ALS Patients with and without C9orf72 and SOD1 Mutations. Cells 12 (6) (2023)
Joke De Vocht, Donatienne Van Weehaeghe, Fouke Ombelet, Pegah Masrori, Nikita Lamaire, Martijn Devrome, Hilde Van Esch, Mathieu Moisse, Michel Koole, Patrick Dupont, Koen Van Laere, Philip Van Damme
Differences in Cerebral Glucose Metabolism in ALS Patients with and without C9orf72 and SOD1 Mutations. Cells 12 (6) (2023)
Gwen Schroyen, Jeroen Blommaert, Donatienne van Weehaeghe, Charlotte Sleurs, Mathieu Vandenbulcke, Nina Dedoncker, Sigrid Hatse, An Goris, Michel Koole, Ann Smeets, Koen van Laere, Stefan Sunaert, Sabine Deprez
Correction: Schroyen et al. Neuroinflammation and Its Association with Cognition, Neuronal Markers and Peripheral Inflammation after Chemotherapy for Breast Cancer. Cancers 2021, 13 , 4198. Cancers 15 (12) (2023)
Gwen Schroyen, Jeroen Blommaert, Donatienne van Weehaeghe, Charlotte Sleurs, Mathieu Vandenbulcke, Nina Dedoncker, Sigrid Hatse, An Goris, Michel Koole, Ann Smeets, Koen van Laere, Stefan Sunaert, Sabine Deprez
Correction: Schroyen et al. Neuroinflammation and Its Association with Cognition, Neuronal Markers and Peripheral Inflammation after Chemotherapy for Breast Cancer. Cancers 2021, 13 , 4198. Cancers 15 (12) (2023)
Joke De Vocht, Donatienne Van Weehaeghe, Fouke Ombelet, Pegah Masrori, Nikita Lamaire, Martijn Devrome, Hilde Van Esch, Mathieu Moisse, Michel Koole, Patrick Dupont, Koen Van Laere, Philip Van Damme
Differences in Cerebral Glucose Metabolism in ALS Patients with and without C9orf72 and SOD1 Mutations. Cells 12 (6) (2023)
Prodromos Gavriilidis, Michel Koole, Salvatore Annunziata, Felix Manuel Mottaghy, Roel Wierts
Positron Range Corrections and Denoising Techniques for Gallium-68 PET Imaging: A Literature Review. Diagnostics (Basel, Switzerland) 12 (10) (2022)
Masoomeh Rahimpour, Marie-Judith Saint Martin, Frédérique Frouin, Pia Akl, Fanny Orlhac, Michel Koole, Caroline Malhaire
Visual ensemble selection of deep convolutional neural networks for 3D segmentation of breast tumors on dynamic contrast enhanced MRI. European radiology (2022)
Jenny Ceccarini, Michel Koole, Koen Van Laere
Cannabinoid receptor availability modulates the magnitude of dopamine release in vivo in the human reward system: A preliminary multitracer positron emission tomography study. Addiction biology 27 (3) (2022)
Wenping Li, Yuchuan Wang, Talakad G Lohith, Zhizhen Zeng, Ling Tong, Robert Mazzola, Kerry Riffel, Patricia Miller, Mona Purcell, Marie A Holahan, Hyking Haley, Liza Gantert, David Hesk, Sumei Ren, John Morrow, Jason Uslaner, Arie Struyk, Jenny Miu-Chun Wai, Michael T Rudd, David M Tellers, Thomas McAvoy, Guy Bormans, Michel Koole, Koen Van Laere, Kim Serdons, Jan de Hoon, Ruben Declercq, Inge De Lepeleire, Maria B Pascual, Paolo Zanotti-Fregonara, Meixiang Yu, Victoria Arbones, Joseph C Masdeu, Amy Cheng, Azher Hussain, Tjerk Bueters, Matt S Anderson, Eric D Hostetler, Anthony S Basile
The PET tracer [ 11 C]MK-6884 quantifies M4 muscarinic receptor in rhesus monkeys and patients with Alzheimer's disease. Science translational medicine 14 (627) (2022)
Kaat Spoormans, Melissa Crabbé, Lara Struelens, Marijke De Saint-Hubert, Michel Koole
A Review on Tumor Control Probability (TCP) and Preclinical Dosimetry in Targeted Radionuclide Therapy (TRT). Pharmaceutics 14 (10) (2022)
Guilherme D Kolinger, David Vállez García, Talakad G Lohith, Eric D Hostetler, Cyrille Sur, Arie Struyk, Ronald Boellaard, Michel Koole
A dual-time-window protocol to reduce acquisition time of dynamic tau PET imaging using [18F]MK-6240. EJNMMI research 11 (1) (2021)
Katja N De Paepe, Ciska-Anne Van Keerberghen, Giorgio Maria Agazzi, Frederik De Keyzer, Olivier Gheysens, Oliver Bechter, Pascal Wolter, Daan Dierickx, Ann Janssens, Gregor Verhoef, Raymond Oyen, Michel Koole, Vincent Vandecaveye
Quantitative Whole-Body Diffusion-weighted MRI after One Treatment Cycle for Aggressive Non-Hodgkin Lymphoma Is an Independent Prognostic Factor of Outcome. Radiology. Imaging cancer 3 (2) (2021)
Christopher Cawthorne, Paul Maguire, Joel Mercier, David Sciberras, Kim Serdons, Guy Bormans, Jan de Hoon, Koen Van Laere, Michel Koole
Human biodistribution and dosimetry of [11C]-UCB-J, a PET radiotracer for imaging synaptic density. EJNMMI physics 8 (1) (2021)
Michel Koole, Donatienne Van Weehaeghe, Kim Serdons, Marissa Herbots, Christopher J Cawthorne, Sofie Celen, Frederick A Schroeder, Jacob M Hooker, Guy Bormans, Jan de Hoon, Janice E Kranz, Koen Van Laere, Tonya M Gilbert
Clinical validation of the novel HDAC6 radiotracer [18F]EKZ-001 in the human brain. European journal of nuclear medicine and molecular imaging 48 (2) (2020)
Heleen Vanhaute, Jenny Ceccarini, Laura Michiels, Michel Koole, Stefan Sunaert, Robin Lemmens, Eric Triau, Louise Emsell, Mathieu Vandenbulcke, Koen Van Laere
In vivo synaptic density loss is related to tau deposition in amnestic mild cognitive impairment. Neurology 95 (5) (2020)
Evy Cleeren, Cindy Casteels, Karolien E Goffin, Michel Koole, Koen Van Laere, Peter Janssen, Wim van Paesschen
Positron emission tomography imaging of cerebral glucose metabolism and type 1 cannabinoid receptor availability during temporal lobe epileptogenesis in the amygdala kindling model in rhesus monkeys. Epilepsia 59 (5) (2018)